• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死患者 PCSK9 与血管内皮功能的关系。

Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction.

机构信息

Maria Cecilia Hospital, GVM Care and Research, via Corriera 1, 48033, Cotignola RA, Italy.

Maria Cecilia Hospital, GVM Care and Research, via Corriera 1, 48033, Cotignola RA, Italy.

出版信息

Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2105-2111. doi: 10.1016/j.numecd.2022.06.020. Epub 2022 Jul 2.

DOI:10.1016/j.numecd.2022.06.020
PMID:35915019
Abstract

BACKGROUND AND AIMS

While the role of PCSK9 in lipid metabolism is well established, its link with endothelial function is less clear. The aim of the present study is to evaluate the relationship between PCSK9 and endothelial dysfunction in the setting of acute myocardial infarction.

METHODS AND RESULTS

To this purpose, we analyzed the serum of 74 patients with ST-elevation myocardial infarction (STEMI) at the time of admission and after 5 days. Endothelial dysfunction was evaluated as rate of apoptosis (AR) of human umbilical vein endothelial cells incubated with patients' serum. There was a good correlation between PCSK9 and the apoptosis rate values, both at baseline (r = 0.649) and 5-day (r = 0.648). In the 5 days after STEMI, PCSK9 increased significantly (242-327 ng/ml, p < 0.001), while AR did not (p = 0.491). Overall, 21 (28%) patients showed a reduction of PCSK9, and they had a significantly higher decrease of AR as compared to others (-13.87 vs 5.8%, p = 0.002). At the univariable analysis, the 5-day change of PCSK9 resulted to be the only variable associated with the 5-day change of the apoptosis rate (beta 0.217, 95%CI 0.091-0.344, p = 0.001).

CONCLUSION

The variation of endothelial function and PCKS9 in the first days after an acute myocardial infarction are related. Further validation and research are necessary to confirm our findings.

CLINICAL TRIAL

NCT02438085.

摘要

背景与目的

虽然 PCSK9 在脂质代谢中的作用已得到充分证实,但它与内皮功能的关系尚不清楚。本研究旨在评估急性心肌梗死(AMI)患者血清中 PCSK9 与内皮功能障碍之间的关系。

方法和结果

为此,我们分析了 74 例 ST 段抬高型心肌梗死(STEMI)患者入院时和 5 天后的血清。内皮功能障碍通过孵育患者血清的人脐静脉内皮细胞(HUVEC)的凋亡率(AR)进行评估。在基线时(r=0.649)和 5 天时(r=0.648),PCSK9 与凋亡率值之间存在良好的相关性。在 STEMI 后的 5 天内,PCSK9 显著增加(242-327ng/ml,p<0.001),而 AR 没有变化(p=0.491)。总的来说,21 名(28%)患者的 PCSK9 减少,与其他人相比,AR 的下降幅度明显更高(-13.87% vs 5.8%,p=0.002)。在单变量分析中,PCSK9 的 5 天变化是唯一与 AR 的 5 天变化相关的变量(β0.217,95%CI 0.091-0.344,p=0.001)。

结论

急性心肌梗死后内皮功能和 PCSK9 的变化相关。需要进一步的验证和研究来证实我们的发现。

临床试验

NCT02438085。

相似文献

1
Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction.急性心肌梗死患者 PCSK9 与血管内皮功能的关系。
Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2105-2111. doi: 10.1016/j.numecd.2022.06.020. Epub 2022 Jul 2.
2
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.PCSK9 抑制剂和依折麦布降低心血管事件风险的临床实践指南:基于风险分层的推荐意见。
BMJ. 2022 May 4;377:e069066. doi: 10.1136/bmj-2021-069066.
3
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
4
PCSK-9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST-Elevation Myocardial Infarction Patients With Chronic Kidney Disease.前蛋白转化酶枯草溶菌素9(PCSK-9)抑制剂可显著改善慢性肾脏病合并ST段抬高型心肌梗死患者因脂蛋白(a)升高所致的冠状动脉慢血流现象。
Catheter Cardiovasc Interv. 2025 Jul;106(1):396-407. doi: 10.1002/ccd.31543. Epub 2025 Apr 25.
5
Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins.心肌梗死后脂蛋白(a)值升高且接受他汀类药物治疗的高危患者中PCSK9基因的功能获得性变异。
Sci Rep. 2025 Jul 23;15(1):26753. doi: 10.1038/s41598-025-12432-6.
6
Assessing angiographic results of saline autotransfusion and thrombus aspiration in STEMI patients.评估ST段抬高型心肌梗死患者自体盐水输注及血栓抽吸的血管造影结果。
Future Cardiol. 2025 Mar;21(4):237-243. doi: 10.1080/14796678.2025.2472581. Epub 2025 Mar 4.
7
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
8
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.ST段抬高型心肌梗死合并多支血管病变时完全血运重建与仅罪犯血管血运重建的比较
Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Disulfidptosis-related gene in acute myocardial infarction and immune microenvironment analysis: A bioinformatics analysis and validation.急性心肌梗死中与二硫化物诱导细胞死亡相关的基因及免疫微环境分析:一项生物信息学分析与验证
PLoS One. 2024 Dec 12;19(12):e0314935. doi: 10.1371/journal.pone.0314935. eCollection 2024.
2
Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.探索前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂研究的研究趋势和热点:一项涵盖2007年至2023年的文献计量学与可视化分析
Front Cardiovasc Med. 2024 Nov 22;11:1474472. doi: 10.3389/fcvm.2024.1474472. eCollection 2024.
3
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand?
可溶性前蛋白转化酶枯草溶菌素9抑制:适应证、临床影响、新分子见解及实践方法——我们目前的进展如何?
J Clin Med. 2023 Apr 18;12(8):2922. doi: 10.3390/jcm12082922.